Newtopia Reports Fourth Quarter and Full Year 2022 Financial Results
- Record annual engagements of 149,000, an increase of 10% year-over-year
- Revenue up 30% and 7% year-over-year for the fourth quarter and full year 2022, respectively
- Multi-year contract renewals across installed client base in 2022
- Ongoing cost optimization to position Company toward profitability in 2023
- Q4 and FY 2022 conference call scheduled for
April 18, 2023 at5 pm ET
Fourth Quarter 2022 Financial Highlights (vs. Q4 2021):
- Revenue of
$3.1 million , as compared to$2.4 million . - Gross profit margin1 of 65%, as compared to 52%.
Full Year 2022 Financial Highlights (vs. 2021):
- Revenue of
$11.2 million , as compared to$10.5 million . - Gross profit margin1 of 54%, as compared to 49%.
"The past twelve months were crucial to the lifecycle and development of Newtopia. Not only did we grow our revenue year-over-year, but we also achieved a record number of engagements on our platform, actively expanded our gross margins, and secured multi-year contract renewals across our installed client base. Following a strategic pivot taken in the third quarter in which we re-evaluated our operations and actively cut expenses, Newtopia is on a clear path to profitability in 2023. These accomplishments are a testament to our remarkable team and the industry-leading results delivered by our outcomes-based platform," said
Ruby continued, "Newtopia is sitting at a positive inflection point. We've returned to top-line growth and continued to deepen our relationships with our current client base all while actively expanding our new business pipeline across self-insured employers and innovative health plans. With recent client expansions and multi-year renewals, the prevailing belief that unchecked chronic disease is one of the greatest cost generators across the entire healthcare system, and a new class of effective GLP-1 diabetes and obesity drugs hitting the market requiring effective behavior change for sustained weight loss, there's never been a better time to invest in primary prevention behavior change. We look forward to a successful and profitable 2023."
__________________________ | |
1 | Gross profit is defined as revenue which is comprised of onboarding welcome revenue, ongoing engagement fees and success fees, less cost of sales which is comprised of |
Fourth Quarter 2022 Financial Results
Revenue for the three months ended
Gross profit for the fourth quarter 2022 totaled
Adjusted operating expenses1 for the three months ended
The Company ended the fourth quarter 2022 with approximately
__________________________ | |
1 | Adjusted operating expenses consist of all cash-based technology, sales and marketing and administrative expenses. Adjusted operating expense is not a measure of financial performance under IFRS and should not be considered a substitute for total operating expenses, which we believe to be the most directly comparable IFRS measure. |
2 | Adjusted operating loss consists of adjusted gross profit less adjusted operating expenses. Adjusted gross profit and operating loss is not a measure of financial performance under IFRS and should not be considered a substitute for loss from operations which we believe to be the most directly comparable IFRS measure. |
Full Year 2022 Financial Results
Revenue for the full year ended
Gross profit for the year totaled
Adjusted operating expenses2 for the year totaled
2023 Outlook
Following the momentum heading out of 2022, along with the strength of Newtopia's new business pipeline, the Company anticipates both top and bottom-line year-over-year growth in 2023. In addition, due to continued strategic expense management, including additional expense cuts made in the first quarter of the current year, Newtopia anticipates that the Company is currently on a clear path to Adjusted EBITDA and cash flow positive within 2023. Profitability is anticipated to build throughout the year, with the bottom line improving incrementally each quarter.
Conference Call
The Company will host a conference call today at
A replay of the conference call will be available through
_____________________________ | |
2 | Adjusted operating expenses consist of all cash-based technology, sales and marketing and administrative expenses. Adjusted operating expense is not a measure of financial performance under IFRS and should not be considered a substitute for total operating expenses, which we believe to be the most directly comparable IFRS measure. |
3 | Adjusted operating loss consists of adjusted gross profit less adjusted operating expenses. Adjusted gross profit and operating loss is not a measure of financial performance under IFRS and should not be considered a substitute for loss from operations which we believe to be the most directly comparable IFRS measure. |
About Newtopia
Newtopia is a tech-enabled habit change provider focused on disease prevention and reducing the cost of care for health insurers. As a provider of whole person care, we prevent, reverse and slow the progression of chronic disease while enriching mental health, resilience and overall human performance. Newtopia's programs leverage genetic, social and behavioral insights to create individualized prevention programs with a focus on type 2 diabetes, heart disease, stroke and weight. With a person-centered approach that combines virtual care, digital tools, connected devices and actionable data science, Newtopia delivers sustainable clinical and financial outcomes. To learn more, visit newtopia.com , LinkedIn or Twitter.
Pre-Released Financial Metrics
This news release contains certain pre-released fourth quarter and full year financial metrics. The fourth quarter and full year financial metrics contained in this news release are preliminary and represent the most current information available to the Company's management, as financial closing procedures for the three months and year ended
Forward Looking Statements
This news release contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, and forward looking statements, within the meaning of applicable
Should any factor affect Newtopia's in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, Newtopia does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release, and Newtopia undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law.
Non-GAAP Financial Measures
The Company's financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS"). Management uses certain non-GAAP measures, which are defined in the appropriate sections of this press release, to better assess the Company's underlying performance. These measures are reviewed regularly by management and the Company's Board of Directors in assessing the Company's performance and in making decisions about ongoing operations. In addition, we use certain non-GAAP measures to determine the components of management compensation. We believe that these measures are also used by investors as an indicator of the Company's operating performance. Readers are cautioned that these terms are not recognized GAAP measures and do not have a standardized GAAP meaning under IFRS and should not be construed as alternatives to IFRS terms, such as net income.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Key Financial Measures and Schedule of Non-GAAP Reconciliations
Unaudited Gross Profit Information [1]
Three Months Ended | Twelve Months Ended | |||||||
2022 | 2021 | 2022 | 2021 | |||||
$ | $ | $ | $ | |||||
Revenue | 3,114,317 | 2,402,793 | 11,166,428 | 10,455,848 | ||||
Cost of revenue | (1,079,576) | (1,164,683) | (5,140,369) | (5,384,184) | ||||
Gross profit | 2,034,741 | 1,238,110 | 6,026,059 | 5,071,664 | ||||
Gross margin | 65 % | 52 % | 54 % | 49 % | ||||
Reconciliation of Total Unaudited Operating Expenses to Adjusted Operating Expenses [2]
Three Months Ended | Twelve Months Ended | |||||||
2022 | 2021 | 2022 | 2021 | |||||
$ | $ | $ | $ | |||||
Total expenses | 3,624,640 | 3,033,487 | 13,726,522 | 12,721,418 | ||||
Add (Subtract) | ||||||||
Share-based compensation | (88,608) | (139,210) | (492,720) | (1,071,275) | ||||
Depreciation of property and equipment | (6,713) | (15,652) | (46,387) | (66,590) | ||||
Loss on disposal of property and equipment | (15,534) | - | (15,534) | - | ||||
Depreciation of right-of-use asset | (30,791) | (46,188) | (169,370) | (184,767) | ||||
Lease modification | (150,907) | - | (150,907) | - | ||||
Interest on lease obligations | (10,050) | (25,525) | (70,797) | (113,714) | ||||
Interest and accretion expense | (111,564) | (97,338) | (388,448) | (112,990) | ||||
Finance charges | (125,920) | (22,592) | (273,736) | (67,342) | ||||
Capitalized borrowing costs | - | 39,200 | 67,000 | 39,200 | ||||
Foreign exchange loss (gain) | (9,945) | (2,236) | 19,053 | (34,650) | ||||
Impairment of right-of-use asset | (200,168) | - | (200,168) | - | ||||
Amortization of deferred finance charges | (56,903) | (61,471) | (248,813) | (174,397) | ||||
Change in value of derivative liability | - | - | - | 47,508 | ||||
Adjusted operating expenses | 2,817,537 | 2,643,511 | 11,755,695 | 10,963,437 | ||||
Adjusted Unaudited Operating Loss [3]
Three Months Ended | Twelve Months Ended | |||||||
2022 | 2021 | 2022 | 2021 | |||||
$ | $ | $ | $ | |||||
Gross profit | 2,034,741 | 1,238,110 | 6,026,059 | 5,071,664 | ||||
Add amortization of intangibles | 68,838 | - | 68,838 | - | ||||
Adjusted gross profit | 2,103,579 | 1,238,110 | 6,094,897 | 5,071,664 | ||||
Adjusted operating expenses | (2,817,537) | (2,643,511) | (11,755,695) | (10,963,437) | ||||
Adjusted operating loss | (713,958) | (1,405,401) | (5,660,798) | (5,891,773) | ||||
NEWTOPIA INC.
Unaudited Statements of Financial Position
As at
(Expressed in Canadian Dollars)
2022 | 2021 | ||
$ | $ | ||
Assets | |||
Current assets | |||
Cash | 345,950 | 811,584 | |
Trade and other receivables | 1,557,640 | 1,381,977 | |
Contract asset | 190,000 | – | |
Prepaid expenses and deposits | 205,843 | 330,992 | |
Inventories | 325,571 | 131,000 | |
Deferred costs | 76,269 | 162,872 | |
2,701,273 | 2,818,425 | ||
Property and equipment | 8,052 | 66,147 | |
Right–of–use asset | – | 369,538 | |
Intangible asset | 3,235,363 | 2,251,852 | |
5,944,688 | 5,505,962 | ||
Liabilities | |||
Current liabilities | |||
Trade and other payables | 2,584,039 | 1,965,420 | |
Credit facility | 4,823,545 | 2,331,314 | |
Lease obligations | 544,700 | 300,555 | |
Contract liability | – | 144,034 | |
Deferred revenue | 48,185 | 59,549 | |
Debentures | 2,409,103 | – | |
10,409,572 | 4,800,872 | ||
Non–current lease obligations | – | 367,001 | |
Debentures | 1,068,772 | 2,182,403 | |
11,478,344 | 7,350,276 | ||
Equity/Deficit | |||
Common shares | 47,978,992 | 45,177,120 | |
Contributed surplus | 12,861,449 | 11,652,200 | |
Deficit | (66,374,097) | (58,673,634) | |
(5,533,656) | (1,844,314) | ||
5,944,688 | 5,505,962 |
NEWTOPIA INC.
Unaudited Statements of Loss and Comprehensive Loss
Years Ended
(Expressed in Canadian Dollars)
2022 | 2021 | ||
$ | $ | ||
Revenue | 11,166,428 | 10,455,848 | |
Cost of revenue | 5,140,369 | 5,384,184 | |
Gross profit | 6,026,059 | 5,071,664 | |
Operating expenses | |||
Technology and development | 3,923,663 | 3,126,963 | |
Sales and marketing | 2,720,728 | 3,156,822 | |
General and administrative | 5,111,304 | 4,679,652 | |
Share–based compensation | 492,720 | 1,071,275 | |
Depreciation of property and equipment | 46,387 | 66,590 | |
Loss on disposal of property and equipment | 15,534 | – | |
Depreciation of right–of–use asset | 169,370 | 184,767 | |
Lease modification | 150,907 | – | |
12,630,613 | 12,286,069 | ||
Other expenses (income) | |||
Interest on lease obligations | 70,797 | 113,714 | |
Interest and accretion expense | 388,448 | 112,990 | |
Finance charges | 273,736 | 67,342 | |
Capitalized borrowing costs | (67,000) | (39,200) | |
Foreign exchange (gain)/loss | (19,053) | 34,650 | |
Impairment of right–of–use asset | 200,168 | – | |
Loss on settlement of debt | – | 18,964 | |
Amortization of deferred finance charges | 248,813 | 174,397 | |
Change in value of derivative liability | – | (47,508) | |
1,095,909 | 435,349 | ||
Net loss and comprehensive loss | (7,700,463) | (7,649,754) |
NEWTOPIA INC.
Unaudited Statements of Changes in Equity (Deficit)
Years Ended
(Expressed in Canadian Dollars)
Common Shares | Shares To Be Issued | Contributed Surplus |
Deficit |
Total | |
$ | $ | $ | $ | $ | |
Balance, | 44,648,952 | 528,168 | 10,046,621 | (51,023,880) | 4,199,861 |
Net loss and comprehensive loss | – | – | – | (7,649,754) | (7,649,754) |
Share–based compensation | – | – | 1,071,275 | – | 1,071,275 |
Warrants issued on issuance of 8% Debenture Units | – | – | 216,588 | – | 216,588 |
Issuance of shares | 528,168 | (528,168) | – | – | – |
Settlement of related party payable | – | – | 317,716 | – | 317,716 |
Balance, | 45,177,120 | – | 11,652,200 | (58,673,634) | (1,844,314) |
Net loss and comprehensive loss | – | – | – | (7,700,463) | (7,700,463) |
Share–based compensation | – | – | 492,720 | – | 492,720 |
Private Placement Offering of Units, net of issuance costs | 2,624,495 | – | 511,839 | – | 3,136,334 |
Compensation options issued to brokers | (83,230) | – | 83,230 | – | – |
Adjustment of issuance costs of 8% Debenture Units | – | – | 4,733 | – | 4,733 |
Shares issued on issuance of 13% Debenture Units | 260,607 | – | – | – | 260,607 |
Settlement of related party payable | – | – | 116,727 | – | 116,727 |
Balance, | 47,978,992 | – | 12,861,449 | (66,374,097) | (5,533,656) |
NEWTOPIA INC.
Unaudited Statements of Cash Flows
Years Ended
(Expressed in Canadian Dollars)
2022 | 2021 | ||||||
$ | $ | ||||||
Cash flows used in operating activities | |||||||
Net loss and comprehensive loss | (7,700,463) | (7,649,754) | |||||
Items not involving cash: | |||||||
Depreciation of property and equipment | 46,387 | 66,590 | |||||
Depreciation of right–of–use asset | 169,370 | 184,767 | |||||
Impairment of right–of–use asset | 200,168 | – | |||||
Lease modification | 150,907 | – | |||||
Amortization of intangible asset | 68,838 | – | |||||
Amortization of deferred finance charges | 248,813 | 174,397 | |||||
Capitalized borrowing costs | (67,000) | (39,200) | |||||
Accretion expense | 184,848 | 62,090 | |||||
Interest on lease obligations | 70,797 | 113,714 | |||||
Loss on disposal of property and equipment | 15,534 | – | |||||
Change in value of derivative liability | – | (47,508) | |||||
Share–based compensation | 492,720 | 1,071,275 | |||||
Loss on settlement of debt | – | 18,964 | |||||
(6,119,081) | (6,044,665) | ||||||
Change in non–cash working capital | |||||||
Trade and other receivables | (175,663) | (314,854) | |||||
Prepaid expenses and deposits | 125,149 | 134,293 | |||||
Inventories | (194,571) | 147,696 | |||||
Trade and other payables | 794,346 | (94,221) | |||||
Contract asset/liability | (334,034) | 162,844 | |||||
Deferred revenue | (11,364) | 59,549 | |||||
(5,915,218) | (5,949,358) | ||||||
Cash flows used in investing activities | |||||||
Purchase of property and equipment | (3,826) | (2,824) | |||||
Intangible asset development costs | (985,349) | (2,143,704) | |||||
(989,175) | (2,146,528) | ||||||
Cash flows from financing activities: | |||||||
Credit facility withdrawals | 9,396,285 | 6,352,152 | |||||
Credit facility repayments | (6,904,054) | (4,020,838) | |||||
Credit facility financing costs | (162,210) | (105,180) | |||||
Proceeds from promissory notes | 550,000 | – | |||||
Repayment of promissory notes | (550,000) | – | |||||
Proceeds from debenture units, net of closing costs | 1,316,964 | 2,336,901 | |||||
Repayment of lease obligation | (344,560) | (329,248) | |||||
Proceeds from private placement offering, net of share | 3,136,334 | – | |||||
6,438,759 | 4,233,787 | ||||||
Net change in cash during the year | (465,634) | (3,862,099) | |||||
Cash, beginning of year | 811,584 | 4,673,683 | |||||
Cash, end of year | 345,950 | 811,584 | |||||
View original content to download multimedia:https://www.prnewswire.com/news-releases/newtopia-reports-fourth-quarter-and-full-year-2022-financial-results-301801024.html
SOURCE Newtopia Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intel (INTC) PT Lowered to $92 at Mizuho
- Stronghold Details Two Years of Competitive Procurement, $8 Million Invested, and Substantive Work Delivered as Part of Its Contractual Obligations
- Greenberg Traurig's Allison Ng Named NAPABA 'Best Under 40'
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Twitter, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share